The legacy success of sildenafil has undeniably shaped the drug landscape. However, putting money in companies heavily reliant on copycat drugs and the diminishing patent rights surrounding this flagship https://bookmarketmaven.com/story22233476/the-blue-pill-and-drugmakers-a-risky-venture